20/04/2026
This editorial highlights that EV‑ diagnostics and therapies are the frontier of , where integration, sensitive detection, and intelligent delivery are advancing into a precision paradigm.
Read :
This editorial discusses extracellular vesicle‑miRNAs as early biomarkers and therapeutic targets, redefining precision care in acute myocardial infarction.